Kellett Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Kellett Wealth Advisors's ABBV Position: Q3 2026 in Review
Kellett Wealth Advisors increased its AbbVie (ABBV) stake by 1.8% in Q3 2026, buying an estimated $15.6K and bringing the position to 3,485 shares worth $912K. The position accounts for 0.33% of the portfolio, ranked #42.
Kellett Wealth Advisors first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. 3,814 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Kellett Wealth Advisors held 3,485 shares of AbbVie worth $912K as of Q3 2026.
- Kellett Wealth Advisors bought 61 AbbVie shares in Q3 2026, an estimated $15.6K.
- AbbVie made up 0.33% of Kellett Wealth Advisors's portfolio in Q3 2026, its #42 holding.
- Kellett Wealth Advisors first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
- 3,814 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Kellett Wealth Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.